New Real World Data of Rivaroxaban in DVT Revealed – MM1601
Results from two real world studies were recently announced – the non-interventional XALIA study in patients with DVT and a study in patients with cancer-associated thrombosis – both showing low rates of major bleeding and recurrent venous thromboembolism (VTE) with rivaroxaban.
Modern Medicine – January 2016
